COMMUNIQUÉS West-GlobeNewswire

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
08/04/2026
DUBLIN and BRIDGEWATER, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today [...]
Le Canada néglige les millions de personnes qui vivent avec l’arthrite, mais un plan audacieux vise à éradiquer la maladie
08/04/2026
Action immédiate contre l’arthrite réunit 21 organisations, plus de 100 000 patients, des chercheurs, des cliniciens et des défenseurs de la cause afin de transformer la recherche sur l’arthrite et les soins au Canada [...]
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
08/04/2026
ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on [...]
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
08/04/2026
Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a new BVA program at a [...]
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
08/04/2026
Nes-Ziona, Israel, April 08, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that Ondo Finance (“ [...]
Canada is Failing Millions Living With Arthritis - But a Bold Plan Aims to End the Disease
08/04/2026
Arthritis Action Now unites 21 organizations, more than 100,000 patients, researchers, clinicians and advocates to transform arthritis research and care in Canada TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Canada is [...]
Life Biosciences Secures $80 Million Series D Financing
08/04/2026
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform BOSTON, April 08, 2026 (GLOBE [...]
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
08/04/2026
Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA, April 08, 2026 (GLOBE [...]
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
08/04/2026
Mesoblast outlines commercial strategy to double net revenues as Ryoncil ® approaches US$100M net revenue milestone since launch last year Showcases transformative blockbuster products for inflammatory back pain and [...]
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
08/04/2026
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment COLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation, Inc. (Ritedose), the largest [...]
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
08/04/2026
ProQR and Ginkgo Bioworks to collaborate on autonomous lab high throughput data generation to support ProQR’s AI-enabled drug discovery for Axiomer™ ProQR establishes AI Advisory Board with leaders from industry and [...]
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
08/04/2026
Preclinical milestone for selection and approval of first compound for lead optimization has been achieved Further development validates the potential intended mechanistic effect of CUE-501 for T cell-mediated targeted [...]
Zelluna ASA – Disclosure of voting rights of Annual General Meeting
08/04/2026
Oslo, April 8, 2026: In connection with the Annual General Meeting of Zelluna ASA to be held on April 23, 2026, Anders Tuv, Chair of the Board of Directors, has, as of the date of this announcement, received proxy-based [...]
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
08/04/2026
PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its [...]
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
08/04/2026
Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Enabling Phase 3 DAYBreak CLL-306 bexobrutideg confirmatory [...]
Clariane annonce l’offre de 500 millions d’euros d’obligations senior en vue de refinancer une partie de son endettement existant
08/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
Clariane has launched a proposed offering of €500 million of senior notes to refinance part of its existing indebtedness
08/04/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane has [...]
AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
08/04/2026
66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohorts Durable responses observed at Day 85: 83% (5/6) (10 mg) [...]
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
08/04/2026
Novonesis expands global footprint with acquisition of production facility in Southeast Asia Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth [...]

Pages